To be successful, your molecule deserves unparalleled experience in Alzheimer’s Disease clinical research. You need a research partner with an uncommon understanding of the complexities associated with evaluating patients with various phenotypes and the ability to implement specific design features to mitigate the risks and challenges specific to Alzheimer’s studies.
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-inhuman through phase IV studies. Grounded in medicine and science, Worldwide Clinical Trials enables sponsors to move from medical discovery into clinical development and commercialization, helping bring innovative solutions to market that deliver enhanced value and improve patient lives. Our employees are among the best in their fields – clinicians, scientists, operational and regulatory specialists who offer expertise across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune mediated inflammatory disorders (IMID), and rare diseases.
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-inhuman through phase IV studies.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs – in the best possible way. From Early Phase and Bioanalytical Sciences through Late Phase and post approval, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world sees CROs – in the best possible way. From Early Phase and Bioanalytical Sciences through Late Phase and post approval, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.
Worldwide Clinical Trials is the leader in CNS clinical research. Our tradition of excellence is founded on therapeutic expertise in CNS disorders, especially psychiatry.
Worldwide’s tradition of excellence is centered on CNS therapeutic expertise and in particular in neurodegenerative disorders such as Parkinson’s disease. Our unparalleled experience in this area allows us not only to understand the complexities associated with Parkinson’s study design, but also to operationally implement specific design features through the use of innovative strategies and tools that mitigate risks and challenges inherent in this type of study.
Worldwide’s tradition of excellence is centered on CNS therapeutic expertise and in particular in neurodegenerative disorders such as Parkinson’s disease. Our unparalleled experience in this area allows us not only to understand the complexities associated with Parkinson’s study design, but also to operationally implement specific design features through the use of innovative strategies and tools that mitigate risks and challenges inherent in this type of study.
Worldwide has extensive capabilities in global analgesia research, including experience with human experimental and clinical models for proof-of-concept in nociceptive and neuropathic pain and for registration studies to support marketing authorization in a number of acute and chronic pain indications.
Worldwide Clinical Trials takes pride in bringing a depth of knowledge to your study based on experience in trials across a range of neurologic disorders. Our clinical experience enables us to work with you at any stage of drug development from Phase I through Phase IV for traditional, as well as, highly innovative clinical targets. Worldwide has participated in the design, execution, or analysis of 105 trials, over 550 sites and 2,840 patients since 2008. Of the 105 total trials, 55 studies have included at least clinical monitoring or project management. A majority of these studies have been conducted globally including unique capabilities in Russia, Ukraine and Eastern Europe.
|
|
|
|
|
|
|
|
|